top of page
Tumor-Infiltrating Lymphocytes
Tumor-Infiltrating Lymphocytes (TILs) are cytotoxic T cells that have migrated into the tumor microenvironment. Isolated directly from fresh human tumor biopsies, TILs are expanded ex vivo using high-dose IL-2 and feeder-based protocols, while preserving their tumor-specific reactivity and T cell receptor (TCR) repertoire.

Tumor-Infiltrating Lymphocytes

$850.00Price
    • 5 mln cells/vial
    • Post-thaw viability - ≥ 80%
    • Cell Type - mostly CD3⁺ T cell
    • Cytokine Production - IFN-γ, TNF-α

    • Adoptive T cell therapy and TIL engineering

    • Tumor immune response and escape mechanism studies

    • Cytotoxicity and functional activation assays

    • Immune checkpoint and T cell exhaustion research

    • Co-culture with autologous tumor cells or 3D models

    • Single-cell immune profiling and TCR sequencing

bottom of page